CID 1219971

132304-37-1

Structural Information

Molecular Formula
C10H16N4O2S
SMILES
CCC1=NN=C(S1)NC(=O)CN2CCOCC2
InChI
InChI=1S/C10H16N4O2S/c1-2-9-12-13-10(17-9)11-8(15)7-14-3-5-16-6-4-14/h2-7H2,1H3,(H,11,13,15)
InChIKey
MJIVQZAYPYEAII-UHFFFAOYSA-N
Compound name
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-morpholin-4-ylacetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

5
References

0
Patents

256.0994 Da
Monoisotopic Mass

0.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 257.10668 156.8
[M+Na]+ 279.08862 162.7
[M-H]- 255.09212 159.7
[M+NH4]+ 274.13322 170.2
[M+K]+ 295.06256 161.2
[M+H-H2O]+ 239.09666 148.2
[M+HCOO]- 301.09760 170.0
[M+CH3COO]- 315.11325 192.4
[M+Na-2H]- 277.07407 157.6
[M]+ 256.09885 156.5
[M]- 256.09995 156.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.